Based on the clinical evidence and the patient profiles where the compound appears most applicable, the following characteristics tend to describe good candidates for AOD 9604 evaluation when it is medically supervised: Patients with stubborn localized fat deposits that have not responded to diet and exercise, particularly visceral and lower abdominal fat Patients who cannot tolerate GLP-1 medications due to nausea, gastrointestinal side effects, or contraindications Active patients with reasonable baseline metabolic health who want a targeted lipolytic tool to complement their training and nutrition program Patients already on a peptide protocol who want to add a fat-targeting element to a GHK-Cu, NAD+, or sermorelin stack Patients who are not candidates for stimulant-based fat loss medications due to cardiovascular sensitivity, anxiety, or blood pressure concerns AOD 9604 is not appropriate as a standalone weight loss strategy for patients with significant obesity, insulin resistance, or metabolic syndrome

Despite being a GH fragment, AOD9604 does not bind with high affinity to the HGH receptor and does not promote cell proliferation in HGH receptor-transfected cells
An evidence-based review of fat modifying supplemental weight loss products
Vitamin B12 is one of those nutrients that you dont think much about until you start to feel the effects of not having enough
With some fine tuning, youll soon experience the many positive effects of restoring your B12 status